The Vox Markets Podcast / Jonathan Tobin, MD of Arix Bioscience discusses one of their portfolio companies, Artios Pharma, that's announced global strategic collaboration with Merck worth $7bn

View our embed guidelines

Sorry, your browser isn't supported.

We recommend upgrading to the latest Chrome, Firefox, Safari, or Edge.

You can visit our support center if you're having problems.